No 10Y consistency score for revenue — its stored periods are half-year spaced, so quarter-over-same-quarter consistency is not computed.
Valuation vs own 10Y history: No P/S history yet
Annual revenue · last 6 fiscal years
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
Revenue growth
33.68%
5Y CAGR
Gross margin
1.15%
TTM
Price / op. cash flow
N/A
trailing two half-years
EV / EBITDA
N/A
trailing two half-years
The latest delayed quote for Haoxi Health Technology Limited (HAO) stock was $2.61 as of Oct 6, 2026, 10:48 AM EDT, down 0.95% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -99.9%
Haoxi Health Technology Limited, operating with its subsidiaries in China, specializes in providing digital marketing services. The company's offerings encompass online short video marketing, which it delivers to advertisers through its network of media partners, alongside custom-designed marketing strategies.
Advertising Agencies · Beijing, BJ
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
N/A
vs Estimate
N/A
Revenue
$21.00M
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1HAO | $914,103 | $2.61 | -0.95% | -99.92% | N/A | N/A | N/A |
| 2KUST | $567,793 | $4.52 | +0.22% | -98.49% | N/A | N/A | vs HAO |
| 3BAOS | $360,604 | $0.23 | -0.84% | -92.88% | -52.37% | N/A | vs HAO |
| 4ONFO | $92,569 | $0.85 | -2.30% | -98.44% | N/A | N/A | vs HAO |
| 5CPOP | $2.35M | $3.10 | -5.37% | -97.43% | -76.06% | N/A | vs HAO |
| 6CNET | $5.75M | $1.57 | -0.77% | -37.90% | -41.37% | -26.17% | vs HAO |
forward FY estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$2.61
High
N/A
